BIBLIOGRAFÍA

1. Blaser, M. Helicobacter pylori and gastric diseases. BMJ. 1998; 316:1507-1510

2. Petersen W, Walsh J. The treatment of Helicobacter infection in the management of peptic ulcer disease. N Eng J Med 1995; 333:984-990

3. Roda E, Festi D, Mazella G, et al. Update on Helicobacter pylori research. Eur J Gastroenterol Hepatol 1997; 9 :613-628

4. Peek R, Blaser M. Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease. Am J Med 1997;102:200-207

5. Graham, DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997;113:1983-1991

6. Mc Farlane, G; Munro, A. Helicobacter pylori and gastric cancer. British Journal of Surgery 1997; 84:1190-1199.

7. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper R. Helicobacter pylori infection and the development of gastric cancer. N Eng J Med 2001; 345: 784-789.

8. Stolte M, Bayerdoffer E, Morgner A, Alpen B, Wundisch T, Thiede C, Neubauer A. Helicobacter and gastric MALT lymphoma. Gut 2002;50 (Suppl III):III19-III24.

9. Breuer T, Goodman K, Malaty H : et al. How do clinicians practicing in the U.S. manage Helicobacter pylori-related gastrointestinal disease. Am J Gastroenterol 1998; 93: 553-561

10. Martínez-Sánchez G, Saperas,E , Benavente J, et al. Actitud de los médicos de atención primaria del área metropolitana de Barcelona frente al diagnostico y tratamiento de la infección por Helicobacter pylori en enfermedades gastroduodenales. Gastroenterologíay hepatología 1998; 21:473-478

11. Sharma V, Vasudeva R, Howden C. A survey of gastroenterologist’s perceptions and practices related to Helicobacter pylori infection. Am J Gastroenterol 1999; 94: 3170-3174

12. Pajares J, Mones J. Encuesta sobre Helicobacter pylori y úlcera péptica en España. Rev Esp Enf Digest 1996; 88:695-699

13. Breuer T, Sudhop T, Goodman G, et al. How do practicing Clinicians manage Helicobacter pylori- related gastrointestinal disease in Germany ? A survey of gastroenterologist and family practitioners. Helicobacter 1998;3:1-8

14. Binek J, Fantin C, Meyenberger C. Attitude to Helicobacter pylori infection among Swiss gastroenterologists. Schweiz Med Wochenschr 1999;129:441-5

15. Mollison L, Jamrozik K, Plant A. Australian doctor’s beliefs and practice regarding Helicobacter pylori . Med J Aust 1999;170:354-7

16. Bardhan, P. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Inf Dis 97; 25:973-978

17. Recavarren-Arce S, Gilman R, Leon-Barua R, et al. Chronic atrophic gastritis: early diagnosis en a population where Helicobacter pylori infection is frequent. Clin Inf Dis 1997; 25:1006-1012.

18. Begue R, Gonzales J, Correa-Gracian, et al. Dietary risk factors associated with the transmision of Helicobacter pylori in Lima, Peru. Am J Trop Med Hyg 1998; 59: 637-640.

19. Ramírez-Ramos A, Gilman R, León-Barua R, et al. Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Clin Inf Dis 1997; 25:1027-10031.

20. Howden C, Hunt R. Guidelines for the management of Helicobacter pylori infection. Am J Gastroenterol1998; 93:2330-2338.

21. Ramírez-Ramos A. Tratamiento de la infección por Helicobacter pylori: Estado actual. Rev Gastroent Peru 1996. Sup 3:S7-19

22. Gilman R, León-Barua E, Ramírez Ramos A, Recavarren S, et al. High rates of recurrence of Helicobacter pylori after triple therapy in Peru. Proceedings of the third Tokyo International Symposium on Helicobacter pylori 1990;3: 233-240

23. Deltenre M, Koster E. How Come I´ve got it? (A Review of helicobacter pylori transmission). Eur J Gastroenterol Hepatol 2000;12:479-482.

24. NIH consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9

25. Williams M, Pounder M. What are the appropiate end-points for Helicobacter pylori eradication in the treatment of duodenal ulcer ?. Drugs 1998; 56:1-10

26. Vásquez A, Valdez Y, Gilman RH et al. Metronidazole and clarithromycin resistance in Helicobacter pylori determined by minimum inhibitory concentrations of antimicrobials in color indicator egg yolk agar in a miniwell format. J Clin Microbiol 1996;34:1232-4

27. Zolezzi A. Tratamiento de la úlcera péptica. Rev Gastroent Peru1998;Sup 1:S44-55

28. Goodwin S. Antimicrobial treatment of Helicobacter pylori infection. Clin Infect Dis 1997;25:1023-6

29. López-Brea M, Alarcón T. Tratamiento de la úlcera péptica y la gastritis asociada a Helicobacter pylori. Enf Infecc Microbiol Clin 1995;13:422-428

30. Meyer JM, Silliman NP, Wang W, Siepman N, Sugg J, Morris D, Zhang J, Bhattacharyya H, King E, Hopkins R. Risk Factors for Helicobacter pylori Resistance in the United States: The Surveillance of H. pylori Antimicrobial Resistance Partnership (SHARP) Study, 1993-1999. Ann Intern Med 2002:136:13-24.